Gå direkt till innehåll

Senaste nyheterna


David Bejker

David Bejker

Presskontakt CEO

Developing Next Generation Biopharmaceuticals

Affibody is a clinical stage Swedish biotech company with a broad product pipeline focused on developing innovative bi- and multi-specific next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.

Affibody AB is a holding of Patricia Industries. For more information on Affibody, please visit the company’s website at www.affibody.com

Scheeles väg 2
SE-171 65 SOLNA